Supernus Pharmaceuticals (SUPN) EBIT (2011 - 2026)
Supernus Pharmaceuticals' EBIT came in at -$57.96 million for Q2 2026, compared with $12.14 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) EBIT (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Supernus Pharmaceuticals reported EBIT of -$109.99 million; for FY2025, it was -$62.28 million.
- Going back by year, EBIT was $81.67 million in FY2024, -$5.27 million in FY2023, $46.12 million in FY2022 (-46.4%) and $86.03 million in FY2021 (-50.5%).
- The five-year range for quarterly EBIT is -$60.23 million (Q3 2025) to $40.85 million (Q3 2024).
- The fastest year-over-year change in EBIT over five years came in Q4 2022 (growth of 463.0%), and the weakest in Q4 2021 (a decline of 85.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn | -57.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -57.96 Mn |
| Dec 31, 2025 | -3.94 Mn |
| Sep 30, 2025 | -60.23 Mn |
| Jun 30, 2025 | 12.14 Mn |
| Mar 31, 2025 | -10.26 Mn |
| Dec 31, 2024 | 21.41 Mn |
| Sep 30, 2024 | 40.85 Mn |
| Jun 30, 2024 | 22.57 Mn |
| Mar 31, 2024 | -3.15 Mn |
| Dec 31, 2023 | -996,000.00 |
| Sep 30, 2023 | 8.14 Mn |
| Jun 30, 2023 | -17.59 Mn |
| Mar 31, 2023 | 5.18 Mn |
| Dec 31, 2022 | 34.33 Mn |
| Sep 30, 2022 | -1.52 Mn |
| Jun 30, 2022 | 11.35 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 6.10 Mn |
| Sep 30, 2021 | 32.60 Mn |
| Jun 30, 2021 | 34.11 Mn |
API Access
Supernus Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();